Position in ROIV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$31,213
+$30,161 QoQ
Shares Held
882
+2221.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#389
of 494 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $3,788,127 across 40 Biotechnology names. ROIV ranks #13 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,349 | $1,663,548 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
8,503 | $463,753 | |
| 3 | INCY |
Incyte Corp
|
3,022 | $342,573 | |
| 4 | NAMS |
NewAmsterdam Pharma Co N.V.
|
8,375 | $283,828 | |
| 5 | TECH |
BIO-TECHNE Corp
|
3,051 | $215,553 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
219 | $136,555 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
524 | $98,134 | |
| 8 | TGTX |
Tg Therapeutics, Inc.
|
1,620 | $89,002 |
All Filings in ROIV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $31,213 | 882 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,052 | 38 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $737 | 34 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $514 | 34 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $597 | 53 | Shares | Sole | 2025-07-14 | |
| 2024-12-31 | $20,193 | 1,707 | Shares | Sole | 2025-01-13 | |
| No filing history on record for this holder in this stock. | ||||||